Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
John Ramsay, Founder and Managing Director of Social-Ability, discusses what rising dementia cases mean for local authorities and social care spending.
A new study, demonstrating how circadian rhythms in heart cells alter daily heart function, may explain why shift workers are vulnerable to heart complications.
Dr Campbell Rogers, Chief Medical Officer at HeartFlow, examines how the healthcare industry can best prepare to combat heart disease in a post-pandemic environment.
Professor Carlos Aguiar, Chair of the European Society of Cardiology (ESC) Communication Committee and spokesperson for Heart Failure, outlines the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
Pascale V Guillot from University College London, Elizabeth Garrett Anderson Institute for Women’s Health, explains stem cell and gene therapy to treat osteogenesis imperfecta, but is this hype or hope?
